Abstract
Diabetic cystopathy is a common and costly complication of the disease. The main driver for bladder dysfunction in this disease process is hyperglycemia. This leads to tissue damage in particularly susceptible cells. In diabetic cystopathy, hyperglycemia contributes to progressive loss of nerve fibers, which affects both the autonomic and somatic divisions of the nervous system. Urologic sequelae of diabetes include lower urinary tract dysfunction as well as sexual dysfunction. The process is slowly progressive and insidious. A common finding is impaired bladder sensation, which can lead to an asymptomatic increase in bladder capacity and urinary retention. The detrusor remodeling that occurs can also cause overactive bladder symptoms. Symptom presentation is widely variable and may go unnoticed for many years. Urodynamics can be the cornerstone of diagnosis in many cases. Treatments vary depending on subtype of bladder dysfunction and generally have lower success rates due to the irreversible loss of detrusor sensory and contractile ability.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Centers for Disease Control and Prevention. Diabetes report card 2017; 2017. www.cdc.gov/diabetes/library/reports/congress.html. Accessed 22 Oct 2018.
Skyler JS, Bakris GL, Bonifacio E, et al. Differentiation of diabetes by pathophysiology, natural history, and prognosis. Diabetes. 2017;66(2):241–55. https://doi.org/10.2337/db16-0806.
Brownlee M. The pathobiology of diabetic complications a unifying mechanism.; 2004. http://diabetes.diabetesjournals.org/content/54/6/1615.full-text.pdf. Accessed 22 Oct 2018.
Charnogursky GA, Emanuele N V, Emanuele MA. Neurologic complications of diabetes. doi:https://doi.org/10.1007/s11910-014-0457-5.
Deli G, Bosnyak E, Pusch G, Komoly S, Feher G. Diabetic neuropathies: diagnosis and management. Neuroendocrinology. 2013;98(4):267–80. https://doi.org/10.1159/000358728.
Yuan Z, Tang Z, He C, Tang W. Diabetic cystopathy: a review. J Diabetes. 2015;7(4):442–7. https://doi.org/10.1111/1753-0407.12272.
Liu RT, Chung MS, Lee WC, et al. Prevalence of overactive bladder and associated risk factors in 1359 patients with type 2 diabetes. Urology. 2011;78(5):1040–5. https://doi.org/10.1016/j.urology.2011.05.017.
Kebapci N, Yenilmez A, Efe B, Entok E, Demirustu C. Bladder dysfunction in type 2 diabetic patients. Neurourol Urodyn. 2007;26:814–9.
Wittig L, Carlson KV, Andrews JM, Crump RT, Baverstock RJ. Diabetic bladder dysfunction: a review. Urology. 2018:10–5. https://doi.org/10.1016/j.urology.2018.10.010.
Daneshgari F, Liu G, Birder L, Hanna-Mitchell AT, Chacko S. Diabetic bladder dysfunction: current translational knowledge HHS Public. Access J Urol. 2009;182:18–26. https://doi.org/10.1016/j.juro.2009.08.070.
Golbidi S, Laher I, Ohlstein E. Bladder dysfunction in diabetes mellitus. Article. 2010;(1):1. https://doi.org/10.3389/fphar.2010.00136.
Winters JC, Dmochowski RR, Goldman HB, et al. AUA/SUFU guideline: adult urodynamics. Am Urol Assoc. 2012:1–30. https://doi.org/10.1016/j.juro.2012.09.081.
Dong X, Song Q, Zhu J, et al. Interaction of Caveolin-3 and HCN is involved in the pathogenesis of diabetic cystopathy. OPEN Nat Publ Gr. 2016; https://doi.org/10.1038/srep24844.
Lee WC, Wu HP, Tai TY, Yu HJ, Chiang PH. Investigation of urodynamic characteristics and bladder sensory function in the early stages of diabetic bladder dysfunction in women with type 2 diabetes. J Urol. 2009;181(1):198–203. https://doi.org/10.1016/j.juro.2008.09.021.
Brown JS, Wing R, Barrett-Connor E, et al. Lifestyle intervention is associated with lower prevalence of urinary incontinence. Diabetes Care. 2006;29(2).
Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the Incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403. https://doi.org/10.1056/NEJMoa012512.
Subak LL, Whitcomb E, Shen H, Saxton J, Vittinghoff E, Brown JS. Weight loss: a novel and effective treatment for urinary incontinence. J Urol. 2005;174(1):190–5. https://doi.org/10.1097/01.ju.0000162056.30326.83.
Cameron AP. Medical management of neurogenic bladder with oral therapy. Transl Androl Urol. 2016;5(1):51–62. https://doi.org/10.3978/j.issn.2223-4683.2015.12.07.
Miyazato M, Yoshimura N, Chancellor MB. The other bladder syndrome: underactive bladder. Rev Urol. 2013;15(1):11–22. https://doi.org/10.3909/riu0558.
Wai CY, Curto TM, Zyczynski HM, et al. Patient satisfaction after midurethral sling surgery for stress urinary incontinence. Obstet Gynecol. 2013;121(5):1009–16. https://doi.org/10.1097/AOG.0b013e31828ca49e.
Kokanali MK, Doǧanay M, Aksakal O, Cavkaytar S, Topçu HO, Özer I. Risk factors for mesh erosion after vaginal sling procedures for urinary incontinence. Eur J Obstet Gynecol Reprod Biol. 2014;177:146–50. https://doi.org/10.1016/j.ejogrb.2014.03.039.
Masumori N, Furuya R, Tanaka Y, Furuya S, Ogura H, Tsukamoto T. The 12-year symptomatic outcome of transurethral resection of the prostate for patients with lower urinary tract symptoms suggestive of benign prostatic obstruction compared to the urodynamic findings before surgery. BJU Int. 2010;105(10):1429–33. https://doi.org/10.1111/j.1464-410X.2009.08978.x.
Gani J, Hennessey D. The underactive bladder: diagnosis and surgical treatment options. Transl Androl Urol. 2017;6(S2):S186–95. https://doi.org/10.21037/tau.2017.04.07.
Daniels DH, Powell CR, Braasch MR, Kreder KJ. Sacral neuromodulation in diabetic patients: success and complications in the treatment of voiding dysfunction. Neurourol Urodyn. 2010;29:578–81. https://doi.org/10.1002/nau.
Dronge AS, S M CB, PK W MB, MP Y. Long-term glycemic control and postoperative infectious complications. Arch Surg. 2006;141(4):375. https://doi.org/10.1001/archsurg.141.4.375.
Feringa HHH, Vidakovic R, Karagiannis SE, et al. Impaired glucose regulation, elevated glycated haemoglobin and cardiac ischaemic events in vascular surgery patients. Diabet Med. 2008;25(3):314–9. https://doi.org/10.1111/j.1464-5491.2007.02352.x.
Sudhakaran S, Surani SR. Guidelines for the management of the diabetic patient. Surg Res Pract 2015;2015.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Bree, K., Santiago-Lastra, Y. (2020). Urological Care for Patients with Diabetes-Induced Lower Urinary Tract Dysfunction. In: Stoffel, J.T., Dray, E.V. (eds) Urological Care for Patients with Progressive Neurological Conditions. Springer, Cham. https://doi.org/10.1007/978-3-030-23277-1_18
Download citation
DOI: https://doi.org/10.1007/978-3-030-23277-1_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-23276-4
Online ISBN: 978-3-030-23277-1
eBook Packages: MedicineMedicine (R0)